Name: QIAGEN N.V. (QGEN) Stock
Brand: QIAGEN N.V.
Rating: 5.5 (3 reviews)

QGEN Latest News, Press Relases and Analysis

All

Press Releases

6 days ago - By: Zacks Investment Research - Mentions: HOLX ABT

Should You Continue to Hold Hologic Stock Post Q4 Earnings?

7 days ago - By: Zacks Investment Research

Qiagen (QGEN) International Revenue in Focus: Trends and Expectations

11 days ago - By: Zacks Investment Research - Mentions: HOLX TMO

Hologic Expands European Reach of Genius Digital Diagnostics System

15 days ago - By: QIAGEN N.V.

QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025

17 days ago - By: Zacks Investment Research

Why Qiagen (QGEN) is a Top Value Stock for the Long-Term

20 days ago - By: Benzinga - Mentions: KURA SEE HRMY FOLD ...

Earnings Scheduled For November 4, 2025

19 days ago - By: The Motley Fool

Qiagen (QGEN) Q3 2025 Earnings Call Transcript

20 days ago - By: Zacks Investment Research

Here's What Key Metrics Tell Us About Qiagen (QGEN) Q3 Earnings

20 days ago - By: Zacks Investment Research - Mentions: DVAX

Qiagen (QGEN) Q3 Earnings and Revenues Surpass Estimates

20 days ago - By: QIAGEN N.V.

QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase

20 days ago - By: QIAGEN N.V.

QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions

25 days ago - By: QIAGEN N.V.

QIAGEN Launches New Automated Sexual Assault Sample Processing Kit at ISHI 2025

a month ago - By: Zacks Investment Research - Mentions: CYTK

Earnings Preview: Cytokinetics (CYTK) Q3 Earnings Expected to Decline

a month ago - By: QIAGEN N.V.

QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing

a month ago - By: Zacks Investment Research - Mentions: ILMN PACB TXG

PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations

a month ago - By: Zacks Investment Research - Mentions: GSK NVS INCY

Will Positive Regulatory Updates Further Boost INCY Stock?

a month ago - By: QIAGEN N.V.

QIAGEN N.V. to Release Results for Q3 2025 and Hold Webcast

2 months ago - By: Zacks Investment Research - Mentions: ILMN TMO MYGN

Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker

2 months ago - By: Zacks Investment Research - Mentions: DGX TMO

Quest Diagnostics Joins Forces With Epic to Improve Laboratory Testing

2 months ago - By: Zacks Investment Research - Mentions: TMO ILMN PACB

PacBio Enters Carrier Screening Market With PureTarget Expansion

2 months ago - By: Zacks Investment Research - Mentions: TMO HOLX QDEL

QuidelOrtho Expands Portfolio With the Launch of FDA-Approved Test

2 months ago - By: Zacks Investment Research - Mentions: DGX EXAS GH

DGX's Haystack Oncology Teams Up With Rutgers Cancer Institute

2 months ago - By: QIAGEN N.V.

QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio

3 months ago - By: Zacks Investment Research - Mentions: HOLX BDX

Hologic's 2025 Outlook Improves on Strong Q3, Easing Tariff Headwinds

3 months ago - By: Zacks Investment Research - Mentions: MASI PAHC NVST

QIAGEN Stock May Benefit From the US Clearance of QIAstat-Dx Rise

3 months ago - By: QIAGEN N.V.

QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing

3 months ago - By: Zacks Investment Research - Mentions: HOLX BSX

The Role of M&A in Hologic's Growth Story: Are More Deals in Sight?

3 months ago - By: Zacks Investment Research - Mentions: NVS INCY

INCY Stock Trading Close to Its 52-Week High: Buy, Sell or Hold?

4 months ago - By: Zacks Investment Research

Why Qiagen (QGEN) International Revenue Trends Deserve Your Attention

4 months ago - By: Benzinga - Mentions: APP CROX JACK TPC ...

DoorDash To Rally Around 30%? Here Are 10 Top Analyst Forecasts For Thursday